Dental sleep medicine is a growing and rewarding niche within sleep medicine. In a recent Sleep Review survey, 4.9% of patients try oral appliances as their first-line therapy, up from an average of 4.2% in our prior survey.
New research shows that an immunoassay can detect a peptide in urine that is increased in children with sleep apnea. The test could provide a psychologically easier way to determine if a child has sleep apnea, an alternative to spending the night in a sleep clinic.
ResMed today introduced its new AirSense 10 PAP device platform, with new features that benefit both the patient and the healthcare provider.
While a lot of news around the fracking boom focuses on environmental impacts, fracking in some areas is having a huge impact on sleep for some people, the Times-Call reports.
In Japan, where workers sleep less, the trend of sleeping in the workplace is growing, The Irish Times reports.
Sleep Review’s 2014 Salary Survey shows a welcome upward trajectory. Most titles show increases compared to our 2013 survey.
Canada-based Ergoresearch Ltd, which designs and manufactures technologies for the orthopedic industry, announced that its wholly owned subsidiary Victhom Laboratory Inc received a net royalty payment of $590,000. That represents its share of the net proceeds generated by the monetization transaction of the sleep apnea technology completed by its German partner Otto Bock Healthcare.
BuzzFeed Blue took four individuals who admitted to not getting enough sleep and had a makeup artist show them how they would look in 20 years if they continued not sleeping enough.
The Chicago Bears have partnered with mattress company Tempur-Pedic to provide their players with quality, restorative sleep during their rigorous training camp.
“We are encouraged by the early positive reception of Hetlioz by patients, physicians, and payors. We look forward to more patients benefiting from Hetlioz in the coming months and years,” says Mihael Polymeropoulos MD, president and CEO of Vanda Pharmaceuticals, in a release about the company’s second quarter 2014 results.